id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1997-P-0417-0005,FDA,FDA-1997-P-0417,Citizen Petition from Bristol-Myers Squibb Co.,Other,Citizen Petition,2011-11-21T05:00:00Z,2011,11,2011-11-21T05:00:00Z,,2025-01-31T20:02:22Z,,0,0,09000064805d428d
FDA-1997-P-0417-0002,FDA,FDA-1997-P-0417,"Acknowledgement letter to McKenna & Cuneo, L.L.P.",Other,Acknowledgement Letter/Receipt,2011-11-21T05:00:00Z,2011,11,2011-11-21T05:00:00Z,,2011-11-21T21:40:44Z,,0,0,0900006480f70c1b
FDA-1997-P-0417-0006,FDA,FDA-1997-P-0417,Acknowledgement letter to Bristol-Myers Squibb Co.,Other,Acknowledgement Letter/Receipt,2011-11-21T05:00:00Z,2011,11,2011-11-21T05:00:00Z,,2011-11-21T22:21:03Z,,0,0,0900006480f70c1e
FDA-1997-P-0417-0001,FDA,FDA-1997-P-0417,"Citizen Petition from McKenna & Cuneo, L.L.P.",Other,Citizen Petition,2011-11-21T05:00:00Z,2011,11,2011-11-21T05:00:00Z,,2025-01-31T19:58:39Z,,0,0,09000064805d428a
FDA-1997-P-0417-0004,FDA,FDA-1997-P-0417,Interim Response from FDA/CDER,Other,Letter(s),2011-11-21T05:00:00Z,2011,11,2011-11-21T05:00:00Z,,2025-01-31T20:01:01Z,,0,0,09000064805d428c
FDA-1997-P-0417-0008,FDA,FDA-1997-P-0417,"Letter from FDA/CDER to McKenna & Cuneo, L.L.P.",Other,Letter(s),2011-11-21T05:00:00Z,2011,11,2011-11-21T05:00:00Z,,2025-01-31T20:07:13Z,,0,0,09000064805d428f
FDA-1997-P-0417-0009,FDA,FDA-1997-P-0417,New Drugs for Human Use; Clarification of Requirements for Patent Holder,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2011-11-21T05:00:00Z,2011,11,1998-03-08T05:00:00Z,1998-06-05T03:59:59Z,2025-01-31T21:08:23Z,98 5800,0,0,09000064805d4291
FDA-1997-P-0417-0007,FDA,FDA-1997-P-0417,"Letter from FDA/CDER to McKenna & Cuneo, L.L.P.",Other,Letter(s),2011-11-21T05:00:00Z,2011,11,2011-11-21T05:00:00Z,,2025-01-31T20:05:00Z,,0,0,09000064805d428e